Vault-13

Summit Rock Advisors, LP

New York, NY · CIK 1540951 · 13F filing filed 2022-08-01

SEC-registered investment adviser since 2007 · limited partnership

As an employer

$122.4m reported value -25.1% vs Q1 2022
8positions
100.0%in top 10
1 new 1 added 1 reduced 1 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SELECT SECTOR SPDR TR ENERGY XLE XLE 843,269 $60.3m49.27% 49.27% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.4m, Q2 2022 843.3k -586.5k -586,480 -41.0%
2 ISHARES TR RUS 2000 VAL ETF IWN IWN 420,000 $57.2m46.72% 46.72% AddedShares held: Q3 2021 414.1k, Q4 2021 283.5k, Q1 2022 302.9k, Q2 2022 420.0k +117.2k +117,150 38.7%
3 VANGUARD INTL EQUITY INDEX F TT WRLD ST ETF VT VT 31,329 $2.7m2.18% 2.18% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 31.3k, Q2 2022 31.3k
4 ADVANCED DRAIN SYS INC DEL COM WMS WMS 7,448 $671.0k0.55% 0.55% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 7.4k
5 DAY ONE BIOPHARMACEUTICALS I COM COM 33,125 $593.0k0.48% 0.48% UnchangedShares held: Q3 2021 0, Q4 2021 33.1k, Q1 2022 33.1k, Q2 2022 33.1k
6 CLOVER HEALTH INVESTMENTS CO COM CL A CLOV CLOV 210,639 $451.0k0.37% 0.37% UnchangedShares held: Q3 2021 210.6k, Q4 2021 210.6k, Q1 2022 210.6k, Q2 2022 210.6k
7 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 34,100 $288.0k0.24% 0.24% UnchangedShares held: Q3 2021 34.1k, Q4 2021 34.1k, Q1 2022 34.1k, Q2 2022 34.1k
8 DYNE THERAPEUTICS INC COM DYN DYN 34,887 $240.0k0.20% 0.20% UnchangedShares held: Q3 2021 0, Q4 2021 34.9k, Q1 2022 34.9k, Q2 2022 34.9k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
MONDAY COM LTD MNDY MNDY 1,676 $265.0k1.7k shares